183 related articles for article (PubMed ID: 2315589)
1. [Vysorel/Isorel--cancer drug from Viscum album. Documentation No.20].
Kast A; Hauser SP
Schweiz Rundsch Med Prax; 1990 Mar; 79(11):332-4. PubMed ID: 2315589
[TBL] [Abstract][Full Text] [Related]
2. [Iscucin--mistletoe preparations for the pre- and postoperative treatment of malignancies. Documentation No. 21].
Kast A; Hauser SP
Schweiz Rundsch Med Prax; 1990 Apr; 79(14):427-9. PubMed ID: 2343229
[TBL] [Abstract][Full Text] [Related]
3. An overview on anticancer activities of the Viscum album extract Isorel.
Zarkovic N; Vukovic T; Loncaric I; Miletic M; Zarkovic K; Borovic S; Cipak A; Sabolovic S; Konitzer M; Mang S
Cancer Biother Radiopharm; 2001 Feb; 16(1):55-62. PubMed ID: 11279798
[TBL] [Abstract][Full Text] [Related]
4. Viscum album L. preparation Isorel modifies the immune response in normal and in tumour-bearing mice.
Jurin M; Zarkovic N; Borovic S; Kissel D
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S27-31. PubMed ID: 9179364
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of Viscum album lectin ML-1 and fresh plant extract (Isorel) on the cell growth in vitro and tumorigenicity of melanoma B16F10.
Zarković N; Kalisnik T; Loncarić I; Borović S; Mang S; Kissel D; Konitzer M; Jurin M; Grainza S
Cancer Biother Radiopharm; 1998 Apr; 13(2):121-31. PubMed ID: 10850348
[TBL] [Abstract][Full Text] [Related]
6. Antitumorous and immunomodulatory effects of the Viscum album L. preparation Isorel.
Jurin M; Zarković N; Hrzenjak M; Ilić Z
Oncology; 1993; 50(6):393-8. PubMed ID: 8233280
[TBL] [Abstract][Full Text] [Related]
7. The Viscum album preparation Isorel inhibits the growth of melanoma B16F10 by influencing the tumour-host relationship.
Zarkovic N; Zarkovic K; Grainca S; Kissel D; Jurin M
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S17-22. PubMed ID: 9179362
[TBL] [Abstract][Full Text] [Related]
8. Perioperative application of the Viscum album extract Isorel in digestive tract cancer patients.
Enesel MB; Acalovschi I; Grosu V; Sbarcea A; Rusu C; Dobre A; Weiss T; Zarkovic N
Anticancer Res; 2005; 25(6C):4583-90. PubMed ID: 16334146
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative and anticarcinogenic effects of an aqueous preparation of Abies alba and Viscum album se abies, on a L-1210 malignant cell line and tumor-bearing Wistar rats.
Karkabounas S; Assimakopoulos D; Malamas M; Skaltsounis AL; Leonce S; Zelovitis J; Stefanou D; Evangelou A
Anticancer Res; 2000; 20(6B):4391-5. PubMed ID: 11205277
[TBL] [Abstract][Full Text] [Related]
10. [Helixor--mistletoe preparation for cancer therapy. Documentation No. 19].
Kast A; Hauser SP
Schweiz Rundsch Med Prax; 1990 Mar; 79(10):291-5. PubMed ID: 2180032
[TBL] [Abstract][Full Text] [Related]
11. [Mistletoe (Viscum album) preparations: an optional drug for cancer patients?].
Bar-Sela G; Gershony A; Haim N
Harefuah; 2006 Jan; 145(1):42-6, 77. PubMed ID: 16450726
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].
Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
Arzneimittelforschung; 2004; 54(8):456-66. PubMed ID: 15460213
[TBL] [Abstract][Full Text] [Related]
13. [Ingredients of mistletoe (Viscum album L.) as potential drugs].
Franz H
Pharmazie; 1985 Feb; 40(2):97-104. PubMed ID: 3889937
[No Abstract] [Full Text] [Related]
14. Adjuvant Cancer Biotherapy by Viscum Album Extract Isorel: Overview of Evidence Based Medicine Findings.
Sunjic SB; Gasparovic AC; Vukovic T; Weiss T; Weiss ES; Soldo I; Djakovic N; Zarkovic T; Zarkovic N
Coll Antropol; 2015 Sep; 39(3):701-8. PubMed ID: 26898069
[TBL] [Abstract][Full Text] [Related]
15. Effects of a standardized mistletoe preparation on metastatic B16 melanoma colonization in murine lungs.
Weber K; Mengs U; Schwarz T; Hajto T; Hostanska K; Allen TR; Weyhenmeyer R; Lentzen H
Arzneimittelforschung; 1998 May; 48(5):497-502. PubMed ID: 9638318
[TBL] [Abstract][Full Text] [Related]
16. [Mistletoe therapy. An alternative cancer treatment].
Ernst E
MMW Fortschr Med; 2000 Nov; 142(45):52-3. PubMed ID: 11107826
[No Abstract] [Full Text] [Related]
17. The influence of isorel on the advanced colorectal cancer.
Cazacu M; Oniu T; Lungoci C; Mihailov A; Cipak A; Klinger R; Weiss T; Zarkovic N
Cancer Biother Radiopharm; 2003 Feb; 18(1):27-34. PubMed ID: 12667306
[TBL] [Abstract][Full Text] [Related]
18. Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study.
Grossarth-Maticek R; Kiene H; Baumgartner SM; Ziegler R
Altern Ther Health Med; 2001; 7(3):57-66, 68-72, 74-6 passim. PubMed ID: 11347286
[TBL] [Abstract][Full Text] [Related]
19. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.
Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
Integr Cancer Ther; 2015 Mar; 14(2):140-8. PubMed ID: 25552476
[TBL] [Abstract][Full Text] [Related]
20. Treatment of advanced pancreatic cancer with mistletoe: results of a pilot trial.
Friess H; Beger HG; Kunz J; Funk N; Schilling M; Büchler MW
Anticancer Res; 1996; 16(2):915-20. PubMed ID: 8687151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]